Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groupsHeba Alshaker, Dmitri Pchejetski, Robert Mills et al.|Journal of Translational Medicine|2021Cited by 22
Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profilingEwan Hunter, Dmitri Pchejetski, Heba Alshaker et al.|Journal of Translational Medicine|2025Cited by 14
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcomeEwan Hunter, Alexandre Akoulitchev, Christina Koutsothanasi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 9
Development and evaluation of blood-based prognostic biomarkers for COVID disease outcomes using EpiSwitch 3-dimensional genomic regulatory immuno-genetic profilingEwan Hunter, J. M. MELLOR, Dmitri Pchejetski et al.|Medical Research Archives|2024Cited by 2
MP35-13 WHITE BLOOD CELLS FROM PROSTATE CANCER PATIENTS CARRY DISTINCT CHROMOSOME CONFORMATIONSDmitri Pchejetski, Mathias Winkler, Taimur T. Shah et al.|The Journal of Urology|2018Cited by 0